← All Metsera, INC filings

Metsera, INC S-1 registration statements

Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.

MTSR
Metsera, INC
S-1/A: Metsera, Inc. Amends Bylaws Ahead of Public Offering, Outlines Stockholder Meeting Procedures
Metsera, Inc. has filed an amended and restated bylaws document detailing procedures for stockholder meetings, director nominations, and corporate governance ahead of its initial public offering.
MTSR
Metsera, INC
S-1: Metsera Files for IPO, Aiming to Revolutionize Obesity Treatment with Novel Peptide Therapies
Metsera, a clinical-stage biotech, is going public to fund its innovative pipeline of injectable and oral NuSH analog peptides targeting obesity and overweight, seeking to overcome limitations of existing treatments.